V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009591 | 260006165 | null | 88.6 | Curative (C) | 2018-07-01 | 2018-08-06 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260006047 | RITUXIMAB |
| 260009592 | 260006165 | 1.56 | 70.2 | Palliative (P) | 2017-09-12 | 2017-09-11 | BEAM | 2 | N | 260006047 | RITUXIMAB |
| 260009593 | 260006166 | null | 93.8 | Curative (C) | 2015-05-08 | 2015-05-31 | 111 Trial (formerly BEP 111) | N | N | 260006175 | BRENTUXIMAB |
| 260009594 | 260006167 | 1.69 | 85.8 | Palliative (P) | 2013-07-16 | 2013-07-16 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260006293 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260009595 | 260006168 | 1.76 | 66.4 | Curative (C) | null | 2015-10-24 | EP | 2 | N | 260006315 | CISPLATIN + ETOPOSIDE |
| 260009596 | 260006168 | null | 60 | Curative (C) | 2018-02-10 | 2018-02-14 | Rituximab | N | null | 260006315 | FEC |
| 260009597 | 260015671 | 1.65 | 91 | Curative (C) | 2014-11-27 | 2014-12-02 | Carboplatin + Paclitaxel (3 weekly) | 0 | Y | 260006339 | RITUXIMAB |
| 260009598 | 260006169 | 1.79 | null | Neo-adjuvant (N) | 2017-01-26 | 2017-02-06 | Pazopanib | N | N | 260006496 | NOT MATCHED |
| 260009599 | 260012311 | 1.81 | 72.3 | null | 2018-08-29 | 2018-09-02 | CISPLATIN + ETOPOSIDE | 02 | null | 260006497 | CISPLATIN + ETOPOSIDE |
| 260009600 | 260015672 | 1.73 | 87.1 | Palliative (P) | 2015-05-13 | 2015-06-04 | Cisplatin + Etoposide (5 day) | N | N | 260006509 | CISPLATIN + ETOPOSIDE |
| 260009601 | 260015672 | 1.82 | 95 | Disease modification (D) | 2018-03-25 | 2018-03-25 | CYCLO + RITUXIMAB + VINCRISTINE | 1 | N | 260006509 | IVA |
| 260009602 | 260015672 | 1.6 | 69.4 | Curative (C) | 2015-11-22 | 2015-12-10 | Rituximab (Maintenance) | 02 | N | 260006509 | SUNITINIB |
| 260009603 | 260015672 | null | null | Curative (C) | null | 2017-01-16 | Bendamustine +/- Prednisolone | N | N | 260006509 | CISPLATIN + ETOPOSIDE |
| 260009604 | 260006170 | null | 91.6 | Curative (C) | 2017-06-06 | 2017-06-11 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260006782 | CARBOPLATIN + ETOPOSIDE |
| 260009605 | 260006171 | 1.69 | 111.9 | null | 2015-01-08 | 2015-01-09 | Cisplatin + Etoposide (5 day) | 2 | N | 260006791 | CISPLATIN + ETOPOSIDE |
| 260009606 | 260012312 | null | null | Palliative (P) | 2017-08-27 | 2017-08-27 | Trial Unspecified | 2 | N | 260006806 | CISPLATIN + ETOPOSIDE |
| 260009607 | 260006172 | 1.8 | 64 | Not known (9) | 2014-08-22 | 2014-09-05 | Cisplatin + Etoposide (5 day) | 02 | N | 260006844 | EP |
| 260009608 | 260006173 | null | 107 | Curative (C) | 2015-08-30 | 2015-08-30 | CISPLATIN + ETOPOSIDE | 2 | N | 260006875 | CISPLATIN + ETOPOSIDE |
| 260009609 | 260012313 | null | 81.7 | Palliative (P) | 2018-07-10 | 2018-07-12 | Carboplatin + Etoposide IV 3 day | N | N | 260006950 | CISPLATIN + ETOPOSIDE |
| 260009610 | 260006174 | 1.6 | null | Curative (C) | null | 2018-05-27 | Rituximab | 2 | null | 260006996 | CETUXIMAB |
| 260009611 | 260006174 | null | 98.2 | null | 2018-04-25 | 2018-04-27 | Cisplatin + Etoposide (5 day) | N | N | 260006996 | CARBOPLATIN + ETOPOSIDE |
| 260009612 | 260006175 | 1.8 | 69.1 | Disease modification (D) | 2017-05-28 | 2017-05-28 | EP | 01 | N | 260007060 | NOT MATCHED |
| 260009613 | 260012315 | 1.62 | 0 | Palliative (P) | 2014-01-24 | 2014-02-06 | Rituximab | N | N | 260007079 | RITUXIMAB |
| 260009614 | 260006176 | null | 91.5 | Curative (C) | 2014-01-02 | 2014-01-03 | Cisplatin + Etoposide (5 day) | N | N | 260007113 | EP |
| 260009615 | 260006176 | null | null | null | 2018-08-16 | 2018-09-02 | Trial Unspecified | N | N | 260007113 | ETOPOSIDE |
| 260009616 | 260006176 | 1.71 | null | Disease modification (D) | 2016-06-09 | 2016-06-10 | Cisplatin + Etoposide (3 day) | N | N | 260007113 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009617 | 260006177 | 1.65 | 98.8 | Curative (C) | 2018-12-30 | 2019-01-05 | GC Int Guide Excranial GermCell JEB | N | N | 260007178 | CETUXIMAB |
| 260009618 | 260006178 | 1.59 | 83.2 | Curative (C) | 2015-06-18 | 2015-06-28 | CARBOPLATIN + PACLITAXEL | 2 | N | 260007190 | RITUXIMAB |
| 260009619 | 260006179 | 1.84 | null | Disease modification (D) | 2015-12-26 | 2016-02-19 | Cisplatin + Etoposide (3 day) | N | N | 260007196 | TIP |
| 260009620 | 260012317 | 1.61 | 57 | null | 2015-02-28 | 2015-03-02 | Cisplatin + Etoposide (5 day) | N | null | 260007208 | CISPLATIN + ETOPOSIDE |
| 260009621 | 260006180 | null | 84.2 | null | null | 2014-12-11 | CISPLATIN + ETOPOSIDE | N | null | 260007242 | ICE |
| 260009622 | 260006180 | null | 102.4 | Curative (C) | null | 2014-08-23 | CISPLATIN + ETOPOSIDE | null | null | 260007242 | NOT MATCHED |
| 260009623 | 260006180 | null | 78 | null | null | 2015-07-23 | Trial Unspecified | null | null | 260007242 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260009624 | 260006181 | 1.76 | 69 | Disease modification (D) | 2017-04-30 | 2017-05-03 | Rituximab | N | N | 260007271 | CISPLATIN |
| 260009625 | 260006181 | null | 90 | Curative (C) | 2016-09-21 | 2016-09-24 | Cisplatin + Etoposide (3 day) | 02 | N | 260007271 | CISPLATIN + ETOPOSIDE |
| 260009626 | 260006182 | 1.73 | null | Palliative (P) | 2016-08-22 | 2016-08-26 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260007297 | NOT MATCHED |
| 260009627 | 260012320 | 1.6 | 0 | Curative (C) | 2017-12-29 | 2017-12-29 | Rituximab | 02 | N | 260007307 | RITUXIMAB |
| 260009628 | 260006183 | 1.68 | 71 | null | 2017-10-07 | 2017-10-09 | Rituximab | N | N | 260007318 | CISPLATIN + RT |
| 260009629 | 260006183 | 1.72 | null | Palliative (P) | 2013-05-02 | 2013-05-19 | Chlorambucil + Pred + Rituximab | N | N | 260007318 | EP |
| 260009630 | 260006184 | 1.72 | 76.4 | Curative (C) | 2015-03-13 | 2015-04-03 | ETOPOSIDE | N | N | 260007355 | DOXORUBICIN + IFOSFAMIDE |
| 260009631 | 260012322 | 1.77 | null | Palliative (P) | 2015-07-02 | 2015-07-30 | Cisplatin + Etoposide (5 day) | N | N | 260007382 | DOXORUBICIN + IFOSFAMIDE |
| 260009632 | 260006185 | 1.8 | null | Palliative (P) | 2013-07-25 | 2013-07-26 | Carboplatin + Etoposide IV 3 day | N | N | 260007421 | CISPLATIN + ETOPOSIDE |
| 260009633 | 260006186 | 1.84 | 93.5 | Palliative (P) | 2017-02-23 | 2017-03-15 | Cisplatin + Etoposide (3 day) | N | N | 260007437 | CISPLATIN |
| 260009634 | 260006186 | 1.81 | 69.8 | Palliative (P) | 2018-12-29 | 2019-01-06 | Rituximab (Maintenance) | 2 | N | 260007437 | GEMCARBO |
| 260009635 | 260006186 | 1.8 | 137 | Disease modification (D) | 2017-01-01 | 2017-01-08 | EP | 2 | N | 260007437 | CISPLATIN + ETOPOSIDE |
| 260009636 | 260006187 | 1.81 | 57 | Palliative (P) | 2016-05-10 | 2016-05-16 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260007482 | RITUXIMAB |
| 260009637 | 260006187 | null | null | Neo-adjuvant (N) | 2016-03-29 | 2016-07-14 | Trial Unspecified | N | N | 260007482 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260009638 | 260006188 | 1.71 | 86 | Disease modification (D) | 2016-08-20 | 2016-08-20 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | Y | 260007508 | TRIAL |
| 260009639 | 260006188 | null | 85 | Disease modification (D) | 2019-01-02 | 2019-01-09 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | N | 260007508 | TRIAL |
| 260009640 | 260006189 | 1.67 | 92.6 | Curative (C) | 2018-10-17 | 2018-10-17 | Rituximab | 02 | N | 260007540 | CISPLATIN + RT |